• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS DE MEXICO PRECISE PRO RX CAROTID STENT SYSTEM; SELF EXPANDING STENTS (NIM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS DE MEXICO PRECISE PRO RX CAROTID STENT SYSTEM; SELF EXPANDING STENTS (NIM) Back to Search Results
Catalog Number PC0840RXC
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Paresis (1998)
Event Date 06/25/2014
Event Type  Injury  
Event Description
During carotid stenting of the left carotid artery with a 5mm angioguard embolic protection device and an 8x40mm precise stent, after deployment of the precise stent, it did not fully expand.Upon further review, it was noted that the devices did not enter the target lesion but were in a side branch.The patient was also not responsive on the right hand and foot.Another stent was deployed in the ica.Access was via the right groin.It was a type 1 arch with ct pictures prior to case.There was approximately 70% stenosis in the ica 1.5cm above the bifurcation.The lesion length was approximately 2cm.Approximately 7000 units of heparin was given and act was 217.The physician utilized a glide wire to position the sheath in the common carotid.Both physicians believed that the 5mm angioguard tracked up the common carotid and into the distal ica.Once the angioguard was deployed, the physicians saw 4 markers separate as a confirmation.Following the deployment of the angioguard, an 8x40 precise rx was inserted and positioned over the lesion as it was road mapped on the monitor.When the stent was deployed the proximal end of the stent about 20mm was fully expanded in the cca however beyond the bifurcation the stent only opened about 2mm in diameter the rest of the 20mm of the stent.At first the physicians believed it was a faulty stent but when they took further images at different angles they realized that the angioguard and stent never entered the ica and could have been either outside of the ica or subintimal of the ica.Further neuro checks were done to the patient left hand and feet were responsive but right side was not.At this time the lesion in the ica has not been touched.One of the physician¿s recommended to recapture the angioguard in the recapturing sheath and reposition it in the ica by going through the struts of the 8x40 already deployed precise stent.They had successfully gotten through a strut of the stent.
 
Manufacturer Narrative
Event description continued: and placed the 5mm angioguard in the distal ica.The next step was to create a large enough space to deliver another stent in the cca/diseased ica.Another physician took a 5x20 aviator balloon and positioned it 10mm in the stent (in the cca) and 10mm in the ica.The goal was to crack an opening the 8x40 precise stent strut.An angiogram was taken and it looked to have an opening to be able to deliver a new 8x30 precise stent in the cca/ica.The stent was successfully deployed and was post dilated with the 5x20 aviator balloon.Devices removed and no closure was used.After the case, the physicians believed that the vessels were perforated or gone subintimal.They discussed the case and could not believe that the angioguard had perforated or gone subintimal.There was no resistance when they initially tracked the angioguard up what they had thought was the ica.With further review of the films, they noticed that there was a small side branch 5mm beyond the bifurcation in the ica (just below the lesion) that ran parallel with ica.In the road map view that the operators were looking at and working with, it looked as if they were tracking up the ica there fore they deployed the angioguard and stent in the side branch.No films have been acquired other than 2 still pictures of the discreet side branch that was the culprit.(b)(4).The product remains implanted and is thus not available for analysis.Additional information is pending and will be submitted within 30 days upon receipt.This is one of 2 products involved with the reported event and are associated manufacturer report numbers 1016427-2014-00078 and 9616099-2014-00471.
 
Manufacturer Narrative
During carotid stenting of the left carotid artery with a 5mm angioguard embolic protection device and an 8x40mm precise stent, after deployment of the precise stent, it did not fully expand.Upon further review, it was noted that the devices did not enter the target lesion but were in a side branch.The patient was also not responsive on the right hand and foot.Another stent was deployed in the ica.Access was via the right groin.It was a type 1 arch with ct pictures prior to case.There was approximately 70% stenosis in the ica 1.5cm above the bifurcation.The lesion length was approximately 2cm.Approximately 7000 units of heparin was given and act was 217.The physician utilized a glide wire to position the sheath in the common carotid.Both physicians believed that the 5mm angioguard tracked up the common carotid and into the distal ica.Once the angioguard was deployed, the physicians saw 4 markers separate as a confirmation.Following the deployment of the angioguard, an 8x40 precise rx was inserted and positioned over the lesion as it was road mapped on the monitor.When the stent was deployed the proximal end of the stent about 20mm was fully expanded in the cca however beyond the bifurcation the stent only opened about 2mm in diameter the rest of the 20mm of the stent.At first the physicians believed it was a faulty stent but when they took further images at different angles they realized that the angioguard and stent never entered the ica and could have been either outside of the ica or subintimal of the ica.Further neuro checks were done to the patient left hand and feet were responsive but right side was not.At this time the lesion in the ica has not been touched.One of the physician¿s recommended to recapture the angioguard in the recapturing sheath and reposition it in the ica by going through the struts of the 8x40 already deployed precise stent.They had successfully gotten through a strut of the stent and placed the 5mm angioguard in the distal ica.The next step was to create a large enough space to deliver another stent in the cca/diseased ica.Another physician took a 5x20 aviator balloon and positioned it 10mm in the stent (in the cca) and 10mm in the ica.The goal was to crack an opening the 8x40 precise stent strut.An angiogram was taken and it looked to have an opening to be able to deliver a new 8x30 precise stent in the cca/ica.The stent was successfully deployed and was post dilated with the 5x20 aviator balloon.Devices removed and no closure was used.After the case, the physicians believed that the vessels were perforated or gone subintimal.They discussed the case and could not believe that the angioguard had perforated or gone subintimal.There was no resistance when they initially tracked the angioguard up what they had thought was the ica.With further review of the films, they noticed that there was a small side branch 5mm beyond the bifurcation in the ica (just below the lesion) that ran parallel with ica.In the road map view that the operators were looking at and working with, it looked as if they were tracking up the ica there fore they deployed the angioguard and stent in the side branch.No films have been acquired other than 2 still pictures of the discreet side branch that was the culprit.The product remains implanted and is thus not available for analysis.Device history record (dhr) review was conducted and the product met quality requirements for product acceptance.Hemiplegia is a known potential adverse events associated with carotid stenting.Hemiparesis is weakness on one side of the body.It is less severe than hemiplegia ¿ the total paralysis of the arm, leg, and trunk on one side of the body.Thus, the patient can move the impaired side of their body, but with reduced muscular strength.People with hemiparesis often have difficulties maintaining their balance due to limb weaknesses leading to an inability to properly shift body weight.This makes performing everyday activities such as dressing, eating, grabbing objects, or using the bathroom more difficult.Hemiparesis with origin in the lower section of the brain creates a condition known as ataxia, a loss of both gross and fine motor skills, often manifesting as staggering and stumbling.Pure motor hemiparesis, a form of hemiparesis characterized by sided weakness in the leg, arm, and face, is the most commonly diagnosed form of hemiparesis.Review of the available information suggests that patient factors and procedural may have contributed to the event.There is no evidence to suggest that the event is related to the design or manufacturing process of the device and therefore no corrective actions are required at this time.It was indicated that the device complication of the stent and angioguard being deployed in the side branch was not associated with any device deficiencies.Neither the dhr nor the information available for review indicate that there is a design or manufacturing related issue, therefore, no corrective actions are required.This is one of 2 products involved with the reported event and are associated manufacturer report numbers 1016427-2014-00078 and 9616099-2014-00471.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX CAROTID STENT SYSTEM
Type of Device
SELF EXPANDING STENTS (NIM)
Manufacturer (Section D)
CORDIS DE MEXICO
circuito interior norte #1820
juarez, chihuahua 3258 0
MX  32580
Manufacturer (Section G)
CORDIS DE MEXICO
circuito interior norte #1820
juarez, chihuahua 3258 0
MX   32580
Manufacturer Contact
cecil navajas
miami lakes, FL 33014
63138802
MDR Report Key3936796
MDR Text Key4535099
Report Number9616099-2014-00471
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 06/25/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/15/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2015
Device Catalogue NumberPC0840RXC
Device Lot Number15935231
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received07/29/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GLIDE WIRE5X20 AVIATOR BALLOON
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age69 YR
-
-